The rearing environment likely mediates a substantial portion of NPGIs' so-called "genetic" effects on mental health symptoms, but EPGIs are not currently powerful enough to replace them.
Abstract
Neuropsychiatric polygenic indices (NPGIs) are used as genetic predictors of poor mental health. However, NPGIs are also associated with environmental factors which could affect mental health in adulthood, including the rearing environment. Hence, their "genetic" effects are both direct and environmentally mediated. There is a need to identify alternative genetic predictors without environmental signal. Endophenotype-based polygenic indices (EPGIs) trained on brain structure and function are under-studied alternatives which, due to their relative biological proximity, may exhibit associations with mental health outcomes which are less environmentally mediated than those of NPGIs. Using four representative UK samples (Understanding Society; UKHLS, NCDS, BCS70 and MCS) we employ sex-stratified path models to estimate the direct and environmentally mediated effects of eleven NPGIs and 30 EPGIs on adult mental health, focussing on the rearing environment. The depression NPGI is consistently associated with mental health symptoms across most sex-stratified sub-samples (best meta-analysis beta = 0.091, p 0.001) but demonstrates 1.6 - 24.5% environmental mediation. Seven other NPGIs and three EPGIs show sample- and sex-specific associations with mental health symptoms. NPGIs for attention deficit hyperactivity disorder, depression and substance use disorder are robustly associated with measures of the rearing environment, which in turn are frequently associated with mental health symptoms. Sensitivity analyses find that NPGI associations vary substantially depending on who is included in the sample. In conclusion, the rearing environment likely mediates a substantial portion of NPGIs' so-called "genetic" effects on mental health symptoms, but EPGIs are not currently powerful enough to replace them.
Findings provide proof-of-concept for the utility of pPGSs in psychiatric research, suggesting both genetic contributions to trauma exposure and GxE effects on psychosis risk, as well as supporting pathway-specific contributions beyond general polygenic risk.
G. Trotta, I. Austin-Zimmerman, E. Spinazzola et al.· Translational Psychiatry· 0 citations
Evidence is found for additive effects of other genetic factors in contributing to some latent co-occurring neurodevelopmental and mental health conditions in autism.
Adeniran Okewole, Vincent-Raphaël Bourque, M. Koko et al.· Molecular Psychiatry· 1 citation
This work applies regression analyses to quantify and compare family-based prediction of 12 traits (including IQ, autism- and ADHD-related traits) in 151 probands with XXY or XYY syndrome based on trait measures in 282 of their first-degree family-members to draft a roadmap for refinement of family-based prediction of...
Shara Reimer, Kathleen E. Wilson, L. Schaffer et al.· Journal of Neurodevelopmenta...· 0 citations
Background: Polygenic scores (PGSs) are increasingly used to investigate the genetic architecture of complex traits. In genetics, family study designs are often used to adjust for confounders such as population structure and shared environment. However, family studies may also be particularly vulnerable to to non-rando...
T. Gholipourshahraki, Ciarrah Barry, O. Plana-Ripoll et al.· medRxiv· 0 citations
Findings support a role for USGs in the genetic architecture of SZ and suggest that common variation within this system may link genetic susceptibility to neurodevelopmental processes and cognitive heterogeneity in SZ.
G. Riquelme Alacid, M. Guardiola-Ripoll, C. Almodóvar-Payá et al.· medRxiv· 0 citations
Externalizing and internalizing behaviours capture heritable, transdiagnostic dimensions of psychopathology, but their genetic architecture and links to societal outcomes remain incompletely understood. This study applied a multivariate framework to population-based, non-clinical traits to explore simultaneous genetic...
B. Šakić, M. Klein, N. Roth Mota et al.· European Neuropsychopharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.